MYNZ (Mainz Biomed NV) Other Stockholders Equity : $0.00 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Other Stockholders Equity?

Mainz Biomed NV's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $0.00 Mil.

Mainz Biomed NV's quarterly Other Stockholders Equity increased from Dec. 2023 ($-0.00 Mil) to Jun. 2024 ($-0.00 Mil) and increased from Jun. 2024 ($-0.00 Mil) to Dec. 2024 ($0.00 Mil).

Mainz Biomed NV's annual Other Stockholders Equity increased from Dec. 2022 ($-0.00 Mil) to Dec. 2023 ($-0.00 Mil) and increased from Dec. 2023 ($-0.00 Mil) to Dec. 2024 ($0.00 Mil).

Mainz Biomed NV Other Stockholders Equity Historical Data

The historical data trend for Mainz Biomed NV's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Other Stockholders Equity Chart

Mainz Biomed NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Stockholders Equity

Get a 7-Day Free Trial

Mainz Biomed NV Quarterly Data
	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial									-	-	-	-	-

Mainz Biomed NV Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Mainz Biomed NV Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129

Website

https://www.mainzbiomed.com

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.